Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Antares Pharma (NQ: ATRS )

4.560 USD +0.270 (+6.29%)
Official Closing Price Updated: 7:35 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Antares Pharma

< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
Antares Pharma Announces Full-Year 2021 Revenue Guidance of $175-200 Million
Company updates full-year 2020 revenue guidance to $145-150 million 
From GlobeNewswire News Releases
3 Top Stocks Trading Under $5 a Share
These interesting low-cost stocks have the opportunity to grow. 
Tags OPK FLNT ATRS
From Motley Fool
3 Top Stocks Under $5
These companies offer more potential than the stock price might indicate. 
Tags AMD NIO VZ
From Motley Fool
Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
From GlobeNewswire News Releases
Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference
From GlobeNewswire News Releases
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SRTS AZN IMVT
From Benzinga
Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results
From GlobeNewswire News Releases
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ... 
Tags ACRX AXNX SYBX
From Benzinga
Analysts See 28% Gains Ahead For RYJ
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Antares Pharma to Report Third Quarter 2020 Financial and Operating Results
From GlobeNewswire News Releases
4 Penny Stocks To Buy According To Analysts; 1 With A 189% Target
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Antares Pharma Enters Exclusive License Agreement With Ferring Pharmaceuticals for Nocdurna® in U.S.
Antares Expands Urology Portfolio and Leverages Commercial Organization 
From GlobeNewswire News Releases
Add Up The Parts: VHT Could Be Worth $231
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
First Week of ATRS May 2021 Options Trading
Investors in Antares Pharma Inc. (ATRS) saw new options begin trading this week, for the May 2021 expiration.. 
Tags Stocks
From Market News Video
Antares Pharma to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference
From GlobeNewswire News Releases
Analysts Forecast 13% Upside For ESML
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Antares Pharma Appoints Tram Bui as Vice President of Corporate Communications and Investor Relations
Jack Howarth Retires as Vice President of Corporate Affairs 
From GlobeNewswire News Releases
Antares Pharma Inc (ATRS) Q2 2020 Earnings Call Transcript
ATRS earnings call for the period ending June 30, 2020. 
Tags ATRS Market News
From Motley Fool
Antares Pharma Reports Strong Second Quarter 2020 Operating and Financial Results; Reinstates Full-Year 2020 Revenue Guidance
From GlobeNewswire News Releases
Why Antares Pharma's Stock Is Trading Higher Today
Antares Pharma (NASDAQ: ATRS) shares are trading higher on Monday after the company announced a deal with Lunatus Global to distribute ... 
Tags Benzinga Market News General
From Benzinga
Antares Pharma and Lunatus Enter Into an Exclusive Distribution Agreement for XYOSTED® in Saudi Arabia and the United Arab Emirates
From GlobeNewswire News Releases
Antares Pharma to Report Second Quarter 2020 Operating and Financial Results
From GlobeNewswire News Releases
Analysts Anticipate ESML To Hit $28
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
First Commercial Product Using Antares Pharma’s Multi-Dose Pen Platform Launches in Europe
From GlobeNewswire News Releases
Antares Pharma Appoints Patrick Shea Senior Vice President of Commercial
From GlobeNewswire News Releases
Analysts Anticipate 15% Upside For VTWG
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Antares Pharma to Present at the Raymond James Human Health Innovation Conference
From GlobeNewswire News Releases
Why Is This Fast-Growing Biotech So Undervalued?
Why is a fast-growing company making one of the best testosterone replacement therapies on the market so underappreciated by investors? 
Tags TEVA LLY MYL
From Motley Fool
Antares Pharma to Present at the Jefferies Virtual Healthcare Conference
From GlobeNewswire News Releases
70 Biggest Movers From Yesterday
Gainers Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) shares jumped 130% to close at $17.85 on Tuesday after the company announced ... 
Tags MDGS News MVIS
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.